Academy of Behavioral Medicine Research Annual Conference

行为医学研究学会年会

• 批准号: 9329808
• 负责人: JAMES A MCCUBBIN
• 金额: $ 1.56万
• 依托单位: CLEMSON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-05-01 至 2018-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9329808
• 关键词: Academy; Adherence; Angiogenic Factor; Arousal; Behavior Therapy; Behavioral; Behavioral Medicine; Carcinogens; Cardiovascular Diseases; Charge; Chronic; Chronic Disease; Clinical; Communicable Diseases; Diabetes Mellitus; Diagnosis; Diet; Discipline; Disease; Epidemiology; Etiology; Exposure to; Fertilization; Fostering; Future; Glean; Goals; Health; Health Services Accessibility; Incidence; Inflammation; Institute of Medicine (U.S.); Intervention; Knowledge; Leadership; Learning; Life Style; Malignant Neoplasms; Medical; Mission; Modality; Modeling; Neuroendocrine Tumors; Neurosecretory Systems; Obesity; Pathway interactions; Patients; Policies; Policy Developments; Primary Prevention; Productivity; Psychoneuroimmunology; Public Health; Recommendation; Research; Research Personnel; Research Priority; Risk; Risk Behaviors; Risk Factors; Science; Scientist; Secondary Prevention; Senior Scientist; Sleep; Stress; Therapeutic; Tobacco; Treatment Effectiveness; United States National Academy of Sciences; Work; anticancer research; base; biobehavior; design; health disparity; improved; improved outcome; meetings; mortality; planetary Atmosphere; psychosocial; public health research; racial and ethnic; response; risk sharing; screening; symposium; tertiary prevention; treatment strategy; trend

Abstract The Academy of Behavioral Medicine Research (ABMR) was founded in 1978 at a meeting organized by representatives of the Institute of Medicine of the National Academy of Sciences. Its mission is to promote the highest values in behavioral medicine research, stimulate integration of biomedical and behavioral disciplines, foster scientific integrity, promote research with high potential for improving public health, and support diversity of ideas, disciplines, and scientific representation within the field of behavioral medicine. The objectives of ABMR's annual meetings have been to provide a forum for established scientists and thought leaders working in the field to share cutting-edge ideas to be exchanged in an informal, yet scientifically- charged atmosphere. The criteria for membership in ABMR are high levels of productivity, excellence and broad recognition for their accomplishments. The annual meetings provide a unique opportunity for well-established scientists to learn about the most recent research in the field, to identify important emerging trends in behavioral medicine, and to help guide national research priorities and policy strategies for improving our national public health mission. ABMR's 39th annual meeting will take place on Jun 21-24, 2017 at La Fonda on the Plaza, Santa Fe, NM. The theme of the meeting is Transdiagnostic Risk Mechanisms: Accelerating the Impact of Behavioral Medicine. The overarching purpose of the meeting is to enrich traditional disease-based models of research and practice by focus on risk pathways and behavioral treatment modalities common to multiple chronic diseases, especially as applied to cancer, inflammation, and psychoneuroimmunology. Symposia are designed to promote cross- fertilization and break disease-based silos through organization by transdiagnostic risk factors, with cancer research results integrated within symposia with findings from other diseases that share common risk pathways with cancer. For example, biobehavioral research from multiple chronic disease perspectives can inform cancer research on factors related to exposure to tobacco and other carcinogens, diet and obesity, adherence to screening recommendations, tumor neuroendocrine microenvironment, angiogenesis, factors controlling metastatic pathways, and the patient response to diagnosis and treatment. Support for this conference will help ABMR provide leadership and guidance for the national research agenda in behavioral medicine to improve outcomes for cancer and other chronic, lifestyle-associated diseases with high mortality rates.

抽象的 行为医学研究院 (ABMR) 成立于 1978 年 由美国国家科学院医学研究所代表组织的会议 科学。其使命是促进行为医学研究的最高价值观，激发 生物医学和行为学科的整合，培养科学诚信，促进研究 具有改善公共卫生的巨大潜力，并支持思想、学科和领域的多样性 行为医学领域的科学代表性。 ABMR 的目标 年度会议的目的是为知名科学家和思想领袖提供一个论坛 在该领域工作，分享前沿思想，并以非正式但科学的方式进行交流 充满电的气氛。 ABMR 会员资格的标准是高水平的生产力、 卓越的表现和对其成就的广泛认可。年会提供了 为知名科学家提供了解该领域最新研究的独特机会 领域，以确定行为医学的重要新兴趋势，并帮助指导国家 研究改善我们国家公共卫生使命的优先事项和政策战略。 ABMR 第 39 届年会将于 2017 年 6 月 21 日至 24 日在 La Fonda on the Plaza 举行 新墨西哥州圣达菲。会议主题是跨诊断风险机制：加速 行为医学的影响。此次会议的首要目的是丰富传统文化 基于疾病的研究和实践模型，重点关注风险途径和行为 多种慢性疾病常见的治疗方式，特别是应用于癌症的治疗方式， 炎症和心理神经免疫学。研讨会旨在促进跨界 通过跨诊断风险因素的组织，施肥并打破基于疾病的孤岛， 将癌症研究结果与其他疾病的发现整合到研讨会中 与癌症有共同的风险途径。例如，来自多个领域的生物行为研究 慢性病观点可以为癌症研究提供与烟草接触相关因素的信息 和其他致癌物、饮食和肥胖、遵守筛查建议、肿瘤 神经内分泌微环境、血管生成、控制转移途径的因素，以及 患者对诊断和治疗的反应。对本次会议的支持将有助于 ABMR 为国家行为医学研究议程提供领导和指导 改善癌症和其他高死亡率的慢性、生活方式相关疾病的治疗结果 费率。